E Fund Management Co., Ltd. Alkermes Plc. Transaction History
E Fund Management Co., Ltd.
- $2.07 Billion
- Q1 2025
A detailed history of E Fund Management Co., Ltd. transactions in Alkermes Plc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 14,060 shares of ALKS stock, worth $410,973. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,060
Previous 14,895
5.61%
Holding current value
$410,973
Previous $428,000
8.41%
% of portfolio
0.02%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding ALKS
# of Institutions
409Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$851 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$532 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$345 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$235 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$201 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.8B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...